Literature DB >> 11734434

Alterations in exhaled gas profile during allergen-induced asthmatic response.

S B Khatri1, M Ozkan, K McCarthy, D Laskowski, J Hammel, R A Dweik, S C Erzurum.   

Abstract

The source of exhaled carbon monoxide (CO) and the relationship to airway inflammation are not clear. If CO is produced by the inflamed airway, we hypothesized that inflammation induced by allergen challenge would increase exhaled CO of atopic asthmatics. Eight atopic asthmatics underwent whole lung allergen challenge. CO, nitric oxide (NO), oxygen, and carbon dioxide (CO(2)) were measured simultaneously in exhaled breath which was collected into Mylar balloons before (baseline), immediately after, and at subsequent times after allergen. NO was higher in asthmatics than control subjects at baseline, increased further in seven of the eight asthmatics after allergen, and was inversely correlated to specific conductance. In contrast, exhaled CO of asthmatics was not higher than that of control individuals at baseline, decreased immediately after allergen, and returned to baseline levels during the late asthmatic response. Thus, allergen-induced airway inflammation did not lead to increased exhaled CO in asthma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734434     DOI: 10.1164/ajrccm.164.10.2106119

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

Review 1.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 2.  Nitric oxide metabolism in asthma pathophysiology.

Authors:  Sudakshina Ghosh; Serpil C Erzurum
Journal:  Biochim Biophys Acta       Date:  2011-06-21

3.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

4.  Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications.

Authors:  Gary W Hunter; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

Review 5.  New Insights in Oxidant Biology in Asthma.

Authors:  Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2016-03

Review 6.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

7.  Noninvasive markers of airway inflammation in asthma.

Authors:  Samuel H Wedes; Sumita B Khatri; Renliang Zhang; Weijia Wu; Suzy A A Comhair; Sally Wenzel; W Gerald Teague; Elliot Israel; Serpil C Erzurum; Stanley L Hazen
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

Review 8.  Exhaled carbon monoxide in asthmatics: a meta-analysis.

Authors:  Jingying Zhang; Xin Yao; Rongbin Yu; Jianling Bai; Yun Sun; Mao Huang; Ian M Adcock; Peter J Barnes
Journal:  Respir Res       Date:  2010-04-30

9.  A meta-analysis of the association of exhaled carbon monoxide on asthma and allergic rhinitis.

Authors:  Yu Shaoqing; Zhang Ruxin; Chen Yingjian; Chen Jianqiu; Wang Yanshen; Li Genhong
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

10.  Alterations of the arginine metabolome in asthma.

Authors:  Abigail Lara; Sumita B Khatri; Zeneng Wang; Suzy A A Comhair; Weiling Xu; Raed A Dweik; Melanie Bodine; Bruce S Levison; Jeffrey Hammel; Eugene Bleecker; William Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Douglas Curran-Everett; Benjamin Gaston; Elliot Israel; Nizar Jarjour; Wendy Moore; Stephen P Peters; W Gerald Teague; Sally Wenzel; Stanley L Hazen; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.